Orion - Annual Financial Report

Orion Group Financial Statement documents 2016 and Corporate Governance Statement published

ORION CORPORATION         STOCK EXCHANGE RELEASE 27 FEBRUARY 2017 at 13.00
EET

Orion Group Financial Statement documents 2016 and Corporate Governance
Statement published

Orion Group's Financial Statement documents for 2016 have been published. The
documents are available in Finnish and English on the Company's website at
http://www.orion.fi/en.

The official financial statement documents, which include the financial
statements, the report of the Board of Directors and the auditor's report are
available in Finnish at http://www.orion.fi/yhtiokokous2017.

Orion's Corporate Governance Statement for year 2016, adopted by the Board of
Directors, is published as a separate report in Finnish and English on the
Company's website at http://www.orion.fi/en.


Orion Corporation



 Olli Huotari               Terhi Ormio
 SVP, Corporate Functions   VP, Communications





Contact person:
Tuukka Hirvonen, Communications Manager, IR & Financial Communications
tel. +358 10 426 2721


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish pharmaceutical company - a builder of
well-being. Orion develops, manufactures and markets human and veterinary
pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The
company is continuously developing new drugs and treatment methods. The core
therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS)
disorders, oncology and respiratory for which Orion developes inhaled Easyhaler®
pulmonary drugs. Orion's net sales in 2016 amounted to EUR 1,074 million and the
company had about 3,500 employees. Orion's A and B shares are listed on Nasdaq
Helsinki. Founded in 1917, Orion celebrates its centennial anniversary in 2017.

[]

Priedai:

Orion Corporate Governance Statement 2016.pdf

Orion Financial Statement Documents 2016.pdf